Abstract
Purpose
Many cancer survivors report experiencing somatic symptoms as well as elevated stress. Theoretical models have suggested that physical symptoms generate subjective stress via fears of recurrence or progression. To date, this indirect effect has not been established empirically. This study aimed to provide preliminary evidence as to whether fear of recurrence or progression is an intermediary between somatic symptom severity and perceived stress among heterogeneous cancer survivors.
Methods
Adult cancer survivors (N = 67; median 2.4 years since diagnosis; 34% male) presenting at a hospital survivorship clinic completed measures assessing somatic symptom severity (Patient Health Questionnaire-15 (PHQ-15)), perceived stress (four-item Perceived Stress Scale (PSS-4)), and fear of recurrence or progression (Assessment of Survivor Concerns (ASC)). Interrelatedness among variables was assessed using Pearson correlations. Indirect effects were modeled using 5000-iteration bootstrapping.
Results
Survivors endorsed a range of somatic symptom severity (29% minimal, 39% low, 18% medium, and 14% high). Somatic symptoms, perceived stress, and fear of recurrence or progression were all significantly positively correlated (rs 0.29 to 0.47). Controlling for time since diagnosis, there was a significant indirect effect of somatic symptom severity on stress via fear of recurrence or progression [B = 0.06, SE = 0.04 (95% CI 0.01–0.16)]. The model accounted for more than one third of the variance in perceived stress [R 2 = 0.35, F(3,54) = 9.59, p < 0.001].
Conclusions
Survivors with greater somatic symptoms tended to report higher levels of stress, due in part to elevated fears of recurrence or progression. Our findings support concerns about recurrence or progression as a mechanism underlying stress states in cancer survivors. Efforts to assist survivors with stress management should teach strategies for managing cancer-related uncertainties stemming from somatic symptoms.
Similar content being viewed by others
References
Berger AM, Gerber LH, Mayer DK (2012) Cancer-related fatigue: implications for breast cancer survivors. Cancer 118(S8):2261–2269
Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98(9):1786–1801
Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367(9522):1618–1625
Bloom JR, Stewart SL, Chang S, Banks PJ (2004) Then and now: quality of life of young breast cancer survivors. Psychooncology 13(3):147–160
Stanton AL, Rowland JH, Ganz PA (2015) Life after diagnosis and treatment of cancer in adulthood: contributions from psychosocial oncology research. Am Psychol 70(2):159–174
Osborn RL, Demoncada AC, Feuerstein M (2006) Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 36(1):13–34
Traeger L, Greer JA, Fernandez-Robles C, Temel JS, Pirl WF (2012) Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol 30(11):1197–1205
Simard S, Savard J, Ivers H (2010) Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv 4(4):361–371
Crist JV, Grunfeld EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology 22(5):978–986
Savard J, Ivers H (2013) The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res 74(4):354–360
Thewes B et al (2012) Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho-Oncology 21(6):571–587
Gil KM, Mishel M, Belyea M, Germino LS, Porter L, LaNey IC, Stewart J (2004) Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncol Nurs Forum 31(3):633–639
McGinty HL, Small BJ, Laronga C, Jacobsen PB (2016) Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol 35(1):1–9
Hilton BA (1988) The phenomenon of uncertainty in women with breast cancer. Issues Ment Health Nurs 9(3):217–238
Mckinley ED (2000) Under toad days: surviving the uncertainty of cancer recurrence. Ann Intern Med 133(6):479–480
Nelson JP (1996) Struggling to gain meaning: living with the uncertainty of breast cancer. ANS Adv Nurs Sci 18(3):59–76
Mishel MH (1990) Reconceptualization of the uncertainty in illness theory. Image J Nurs Sch 22(4):256–262
Salkovskis PM, Warwick HM (1986) Morbid preoccupations, health anxiety and reassurance: a cognitive-behavioural approach to hypochondriasis. Behav Res Ther 24(5):597–602
van de Wal MA, Gielissen MF, Servaes P, Knoop H, Speckens AE, Prins JB (2015) Study protocol of the SWORD-study: a randomized controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence. BMC Psychol 3(1):12
Warwick HM (1989) A cognitive-behavioural approach to hypochondriasis and health anxiety. J Psychosom Res 33(6):705–711
Fardell JE et al (2016) Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv:1–11
Dow KH (1995) A review of late effects of cancer in women. Semin Oncol Nurs 11(2):128–136
Eisenberg SA, Kurita K, Taylor-Ford M, Agus DB, Gross ME, Meyerowitz BE (2015) Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors. Psychooncology 24(2):228–235
Sporn NJ, Smith KB, Pirl WF, Lennes IT, Hyland KA, Park ER (2015) Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred? Psychooncology 24(9):1167–1173
Kroenke K, Spitzer RL, Williams JB (2002) The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 64(2):258–266
Kroenke K et al (2010) Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med 170(18):1686–1694
Gotay CC, Pagano IS (2007) Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes 5(1):15
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396
Preacher KJ, Hayes AF (2008) Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 40(3):879–891
Hayes AF (2009) Beyond Baron and Kenny: statistical mediation analysis in the new millennium. Commun Monogr 76(4):408–420
Simmons JP, Nelson LD, Simonsohn U (2011) False-positive psychology undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci:0956797611417632
Bennett MI, Rayment C, Hjermstaf M, Aass N, Caraceni A, Kaasa S (2012) Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain 153(2):359–365
Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(S1):4–10
Koch L et al (2013) Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors—a systematic review of quantitative studies. Psycho-Oncology 22(1):1–11
Cohen S (1988) Perceived stress in a probability sample of the United States
Cohen S, Herbert TB (1996) Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol 47(1):113–142
Glaser R, Kiecolt-Glaser JK (2014) Handbook of human stress and immunity. Academic Press
Antoni MH et al (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6(3):240–248
Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B (2006) Cancer-related worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 15(4):306–320
Gil KM, Mishel MH, Belyea M, Germino B, Porter LS, Clayton M (2006) Benefits of the uncertainty management intervention for African American and white older breast cancer survivors: 20-month outcomes. Int J Behav Med 13(4):286–294
Mishel MH et al (2005) Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors. Psycho-Oncology 14(11):962–978
Lebel S et al (2014) Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 8(3):485–496
Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M, Goodman M, Cox CE, Kip KE (2009) Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology 18(12):1261–1272
Lengacher CA, Johnson-Mallard V, Barta M, Fitzgerald S, Moscoso MS, Post-White J, Jacobsen PB, Shelton MM, Le N, Budhrani P, Goodman M, Kip KE (2011) Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs 29(2):107–117
Lengacher CA, Shelton MM, Reich RR, Barta MK, Johnson-Mallard V, Moscoso MS, Paterson C, Ramesar S, Budhrani P, Carranza I, Lucas J, Jacobsen PB, Goodman MJ, Kip KE (2014) Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trail (RCT). J Behav Med 37(2):185–195
Kim Y, Carver CS, Spillers RL, Love-Ghaffari M, Kaw CK (2012) Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Qual Life Res 21(3):517–525
Fan G (2007) Symptom clusters in cancer patients: a review of the literature. Curr Oncol 14(5):173–179
Acknowledgements
The authors wish to acknowledge the patients who participated in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding source
This study was supported by internal funds from the Massachusetts General Hospital Cancer Center. DLH was supported by an Institutional National Research Service Award (T32AT000051) from the National Center for Complementary and Integrative Health at the National Institutes of Health. ERP was supported by a midcareer investigator award (NCI K24CA197382) from the National Cancer Institute.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Hall, D.L., Lennes, I.T., Pirl, W.F. et al. Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer 25, 1401–1407 (2017). https://doi.org/10.1007/s00520-016-3533-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3533-3